Tirzepatide Lyophilized Nadiifin Sarreysa 99% Peptide Powder TR 10mg 15mg 20mg 30mg halkii dhalo oo loogu talagalay sonkorta dhiigga / sonkorowga

Tirzepatide waa novel gulukoos-ku-tiirsan insulinotropic polypeptide / glucagon-like peptide 1 (GLP-1) receptor agonist oo lagu ansixiyay Maraykanka si loogu daro cuntada iyo jimicsiga si loo wanaajiyo kontoroolka glycemic ee dadka waaweyn ee qaba nooca 2 ee sonkorowga iyo in baaritaan lagu sameeyo isticmaalka maaraynta miisaanka daba dheeraada, dhacdooyinka wadnaha iyo xididada xun ee xun iyo maaraynta xaaladaha kale, oo ay ku jiraan wadnaha oo aan shaqeynin iyo cayil. steatohepatitis aan alkohol ahayn. Wajiga 3 SURPASS 1-5 barnaamijka tijaabada kiliinikada waxaa loogu talagalay in lagu qiimeeyo waxtarka iyo bedqabka tirzepatide-ka-hoosaadka hal mar todobaadkiiba lagu duro (5, 10 iyo 15 mg), sida monotherapy ama isku darka daaweynta, guud ahaan noocyada kala duwan ee dadka qaba nooca 2 ee sonkorowga. Isticmaalka tirzepatide ee daraasadaha kiliinikada ayaa lala xiriiriyay hoos u dhigista hemoglobin glycated (-1.87 ilaa -2.59%, -20 ilaa -28 mmol / mol) iyo miisaanka jidhka (-6.2 ilaa -12.9 kg), iyo sidoo kale hoos u dhigista qiyaasaha sida caadiga ah lala xiriiriyo khatarta wadnaha ee kor u kaca sida cadaadiska dhiigga, visceral visceral. Tirzepatide si wanaagsan ayaa loo dulqaatay, iyadoo leh khatar hoose oo ah hypoglycaemia marka la isticmaalo insulin la'aan ama qarsoodiga insulin waxayna muujisay astaan ​​badbaadada guud ahaan la mid ah fasalka agonist ee GLP-1. Sidaa awgeed, caddaynta tijaabooyinkan caafimaad waxay soo jeedinaysaa in tirzepatide ay bixiso fursad cusub oo hoos u dhigista haemoglobin glycated iyo miisaanka jidhka ee dadka qaangaarka ah ee qaba nooca 2 ee sonkorowga.